Abstract
Trans-acting hammerhead ribozymes are challenging tools for diagnostic, therapeutic, and biosensoristic purposes, owing to their specificity, efficiency, and great flexibility of use. One of the main problems in their application is related to the difficulties in the design of active molecules and identification of suitable target sites.
The aim of this chapter is to describe ALADDIN, “SeArch computing tooL for hAmmerheaD ribozyme DesIgN,” an open-access tool able to automatically identify suitable cleavage sites and provide a set of hammerhead ribozymes putatively active against the selected target.
ALADDIN is a fast, cheap, helpful, and accurate tool designed to overcome the problems in the design of trans-acting minimal hammerhead ribozymes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Citti, L., and Rainaldi, G. (2005) Synthetic hammerhead ribozymes as therapeutic tools to control disease genes, Current Gene Therapy 5, 11–24.
Usman N, Beigelman L, McSwiggen JA. (1996) Hammerhead ribozyme engineering. Current Opinion in Structural Biology 4 527–533.
Kronenwett, R., Haas, R., and Sczakiel, G. (1996) Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes, Journal of Molecular Biology 259, 632–644.
Jarvis, T. C., Wincott, F. E., Alby, L. J., McSwiggen, J. A., Beigelman, L., Gustofson, J., DiRenzo, A., Levy, K., Arthur, M., MatulicAdamic, J., Karpeisky, A., Gonzalez, C., Woolf, T. M., Usman, N., and Stinchcomb, D. T. (1996) Optimizing the cell efficacy of synthetic ribozymes - Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb, Journal of Biological Chemistry 271, 29107–29112.
Scherr, M., and Rossi, J. J. (1998) Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts, Nucleic Acids Research 26, 5079–5085.
Lieber, A., and Strauss, M. (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library, Molecular and Cellular Biology 15, 540–551.
Mir, A. A., Lockett, T. J., and Hendry, P. (2001) Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers, Nucleic Acids Research 29, 1906–1914.
Pan, W. H., Xin, P., Bui, V., and Clawson, G. A. (2003) Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner, Molecular Therapy 7, 129–139.
Ellington, A. D., Chen, X., Robertson, M., and Syrett, A. (2009) Evolutionary origins and directed evolution of RNA, International Journal of Biochemistry & Cell Biology 41, 254–265.
Tedeschi, L., Lande, C., Cecchettini, A., and Citti, L. (2009) Hammerhead ribozymes in therapeutic target discovery and validation, Drug Discovery Today 14, 776–783.
Zuker, M. (1989) On finding all suboptimal foldings of an RNA molecule, Science 244, 48–52.
McCaskill, J. S. (1990) The equilibrium partition function and base pair binding probabilities for RNA secondary structure, Biopolymers 29, 1105–1119.
Ding, Y., and Lawrence, C. E. (2003) A statistical sampling algorithm for RNA secondary structure prediction, Nucleic Acids Research 31, 7280–7301.
Markham, N. R., and Zuker, M. (2008) UNAFold - Software for nucleic acid folding and hybridization, Methods in Molecular Biology:Volume II: Structure, function and applications, 3–31.
Mercatanti, A., Rainaldi, G., Mariani, L., Marangoni, R., and Citti, L. (2002) A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes, Journal of Computational Biology 9, 641–653.
Mathews, D. H., Disney, M. D., Childs, J. L., Schroeder, S. J., Zuker, M., and Turner, D. H. (2004) Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure, Proceedings of the National Academy of Sciences of the United States of America 101, 7287–7292.
Pennati, M., Binda, M., Colella, G., Zoppe, M., Folini, M., Vignati, S., Valentini, A., Citti, L., De Cesare, M., Pratesi, G., Giacca, M., Daidone, M. G., and Zaffaroni, N. (2004) Ribozyme-mediated inhibition of Survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells, Oncogene 23, 386–394.
Citti L, Boldrini L, Nevischi S, Mariani L, Rainaldi G. (1997) Quantitation of in vitro activity of synthetic trans-acting ribozymes using HPLC, Biotechniques, 23, 898–903.
Poliseno L, Bianchi L, Citti L, Liberatori S, Mariani L, Salvetti A, Evangelista M, Bini L, Pallini V, Rainaldi G., (2004), Bcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatment. Biochemical Journal 1;823–832.
Hertel, K.J. et al. (1992) Numbering system for the hammerhead ribozyme. Nucleic Acids Res. 20, 3252.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Mercatanti, A., Lande, C., Citti, L. (2012). A Computational Approach to Predict Suitable Target Sites for trans-Acting Minimal Hammerhead Ribozymes. In: Hartig, J. (eds) Ribozymes. Methods in Molecular Biology, vol 848. Humana Press. https://doi.org/10.1007/978-1-61779-545-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-61779-545-9_21
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-544-2
Online ISBN: 978-1-61779-545-9
eBook Packages: Springer Protocols